… In conclusion, the extreme rarity of pituitary carcinomas is likely the result of multiple,
complex, and highly efficient mechanisms that prevent malignant transformation through the …

… adenomas and pituitary carcinomas. Pituitary adenomas constitute most of the tumors
arising in the pituitary gland and have been historically classified by their histopathological …

… and paragangliomas, gastrointestinal stromal tumors (GISTs), and renal carcinomas [38, 39].
… with colorectal carcinomas, ovarian and endometrial carcinomas, as well as several other …

… , and 39 pituitary carcinomas. The overall standardized incidence rate was 4.8 cases per
100,000 person-years and the annual incidence rate continually trended upwards, with a peak …

… , as part of syndromic diseases or familial isolated pituitary adenomas, and associates to
more aggressive, invasive, and drug-resistant tumors. The vast majority of cases is represented …

… Pituitary adenoma biology has long been a subject of … of significant endocrine disease arising
from pituitary adenomas, … Furthermore, pituitary adenomas are not classified uniformly by …

… ) is a subgroup of aggressive pituitary tumors (accounting for 10% of all hypophyseal
neoplasia) which … of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 178:G1–G24. …

… pituitary tumors. The purpose of this review is to report the role of VEGF in the development
and pathology of pituitary tumors … of pituitary tumors and the progress of anti-VEGF therapy in …

… centers in China, we have diagnosed and treated more than fifty cases of aggressive PA
and 3 pituitary carcinomas in the past 5 years and proposed a new term, ie, refractory PAs, to …

… aggressive pituitary tumours and carcinomas. Moreover, lack of a control group weakens
any conclusion about the therapeutic effects of TMZ. However, the low prevalence of this kind …